Schonfeld Strategic Advisors’s Precision BioSciences DTIL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$223K	Buy	+40,552	New	+$187K	﹤0.01%	1696
2023 Q2	–	Sell	-343	Closed	-$7.76K	–	2222
2023 Q1	$7.76K	Sell	343 -657	-66%	-$21.6K	﹤0.01%	1876
2022 Q4	$35.7K	Sell	1,000 -1,150	-53%	-$45.4K	﹤0.01%	2285
2022 Q3	$83K	Sell	2,150 -442	-17%	-$21K	﹤0.01%	2588
2022 Q2	$124K	Buy	2,592 +439	+20%	+$25.8K	﹤0.01%	2075
2022 Q1	$199K	Buy	+2,153	New	+$293K	﹤0.01%	1970
2021 Q3	–	Sell	-1,183	Closed	-$444K	–	2220
2021 Q2	$444K	Buy	1,183 +656	+124%	+$197K	﹤0.01%	1254
2021 Q1	$164K	Buy	+527	New	+$184K	﹤0.01%	1564

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Schonfeld Strategic Advisors's DTIL Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Precision BioSciences (DTIL) in Q1 2026: 40,552 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #1696 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in DTIL as recently as Q1 2023.

Schonfeld Strategic Advisors first reported a position in DTIL in Q1 2021 and has held it in 8 quarters since. The position peaked at $444K in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Schonfeld Strategic Advisors held 40,552 shares of Precision BioSciences worth $223K as of Q1 2026.
Precision BioSciences was a new Schonfeld Strategic Advisors position in Q1 2026.
Precision BioSciences made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1696 holding.
Schonfeld Strategic Advisors first reported a position in Precision BioSciences in Q1 2021 and has held it in 8 quarters since.
Schonfeld Strategic Advisors's Precision BioSciences position peaked at $444K in Q2 2021.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.